Tesla's Terafab Gamble and Robotaxi Race Converge in High-Stakes Earnings

Tesla's Q1 2026 earnings call faces scrutiny over $25B+ Terafab chip plant costs, new AI5 chip design, and Robotaxi rollout amid delivery concerns.

Tesla shares surged over 16% last week, closing at €341.20 and trimming year-to-date losses to just under 9%. Yet this rally sets the stage for a critical test this Wednesday, April 22, when the company reports quarterly earnings. The real focus for investors will extend far beyond the headline profit per share.

The week's momentum was fueled by two key developments. CEO Elon Musk announced the completion of the design for the new AI5 chip, a process known as tape-out. Slated for high-volume production starting in 2027, this chip is destined not for cars but for Tesla's Optimus humanoid robot and supercomputer clusters. Furthermore, Intel joined as a third manufacturing partner for the massive Terafab project in early April. Tesla is already working with Samsung on a $16.5 billion AI6 deal and with TSMC on the AI5 chip.

However, the most significant—and potentially risky—topic for Wednesday's earnings call is Terafab itself. This planned chip plant in Austin, Texas, is being built with partners at an estimated cost of $25 billion. Musk has called it the world's largest semiconductor factory. Analyst firm Morgan Stanley estimates total costs could reach $35 to $45 billion, with manufacturing equipment alone accounting for $20 to $25 billion. Crucially, CFO Vaibhav Taneja has clarified that Terafab is not included in Tesla's existing capital expenditure forecast of over $20 billion for 2026, with a separate assessment to follow in future quarters. Barclays has warned that communication around these substantial costs could be received negatively by the market.

Parallel to its chip ambitions, Tesla is pushing forward with its autonomous vehicle plans. Drone footage from April 13 showed more than 50 Cybercab units at the Giga Texas facility, with series production slated to begin this month. A regulatory hurdle remains: most visible vehicles still feature steering wheels and pedals, a transitional requirement while Tesla awaits approval for a wheel-less design. Current US safety standards limit such vehicles to 2,500 units annually without an exemption, which Tesla is seeking. The long-term production goal is far more aggressive, with Musk describing an approach closer to consumer electronics, targeting a cycle time of one vehicle every ten seconds at full capacity.

The Robotaxi rollout is also accelerating. Tesla aims to add Dallas, Houston, Phoenix, Miami, Orlando, Tampa, and Las Vegas to its network by the end of June, bringing the total to nine US cities. Approximately 60 specially equipped Model Y vehicles are already stationed in Phoenix. This expansion faces stiff competition; rival Waymo is currently providing 500,000 paid, fully driverless rides per week across ten US cities.

Underlying these ambitious projects are concerning delivery figures. Tesla delivered 358,023 vehicles in Q1 2026, a 6.3% year-over-year increase but below consensus estimates of around 366,000. More telling was a production figure of roughly 408,000 units, leaving a gap of about 50,000 vehicles. J.P. Morgan interprets this inventory build-up as a sign of softening demand and potential margin pressure.

Analyst expectations for the quarter are mixed. The consensus sits at earnings per share of $0.37 on revenue of $22.71 billion. Refinitiv offers a more cautious view, forecasting $0.30 EPS and $21.52 billion in revenue, suggesting a potential negative earnings surprise of around 20-21%. Prediction markets assign a 53% probability that Tesla will either miss or only meet expectations. Analyst ratings reflect this divergence. UBS recently upgraded the stock from "Sell" to "Neutral," maintaining a $352 price target. TD Cowen stays at "Buy" but lowered its target from $519 to $490, while RBC cut its target from $500 to $480, citing competition in China. An aggregate of 48 analysts on MarketScreener shows an average "Outperform" rating with a $415 price target, though the range is wide—from $125 to $600. Morningstar assigns a fair value of $400 and a three-star "fairly valued" rating.

Technically, the stock has broken out of its recent downward channel and sits just above its 50-day moving average. However, the 100-day average does not yet indicate a definitive upward trend, signaling a channel breakout rather than a confirmed reversal.

History shows that beating earnings alone may not be enough. When Tesla exceeded expectations in Q4 2025, its shares still fell 3%. The market's reaction on Wednesday will hinge on how convincingly management frames the massive Terafab investment, provides clarity on 2026 capital expenditure guidance, and details the roadmap for its Robotaxi and Cybercab initiatives.